Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MCD”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Testing effectiveness (Phase 2)Ended earlyNCT05441826
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Minimal Change DiseaseFocal Segmental Glomerulosclerosis
Tenet Medicines 1
Testing effectiveness (Phase 2)Looking for participantsNCT07608978
What this trial is testing

Efficacy and Safety of Polatuzumab Vedotin in Combination With Zanubrutinib, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma of the MCD/BN2/N1 Subtypes

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
The First Affiliated Hospital with Nanjing Medical University 35
Testing effectiveness (Phase 2)Looking for participantsNCT06466135
What this trial is testing

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Who this might be right for
Diabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more
Walden Biosciences 96
Not applicableLooking for participantsNCT02582021
What this trial is testing

WISE CVD - Continuation (WISE HFpEF)

Who this might be right for
Microvascular Coronary DysfunctionCardiovascular Disease
Cedars-Sinai Medical Center 220
Large-scale testing (Phase 3)Study completedNCT00065611
What this trial is testing

Steroid Treatment for Kidney Disease

Who this might be right for
NephrosisFocal Lipoid Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8
Not applicableStudy completedNCT07436169
What this trial is testing

2D:4D Finger Ratio and Breast Cancer in Women

Who this might be right for
Breast CancerAnthropometric MeasurementsFemales
Malatya Turgut Ozal University 132
Early research (Phase 1)Study completedNCT00003761
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 20
Not applicableLooking for participantsNCT02817997
What this trial is testing

International Registry for Patients With Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's DiseaseGiant Lymph Node Hyperplasia+6 more
University of Pennsylvania 1,000
Large-scale testing (Phase 3)Not Yet RecruitingNCT06405100
What this trial is testing

Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

Who this might be right for
Minimal Change Disease
Air Force Military Medical University, China 81
Not applicableUnknownNCT05910151
What this trial is testing

Selective Screening of Children for Hereditary Metabolic Diseases by Tandem Mass Spectrometry in Kazakhstan

Who this might be right for
Propionic/Methylmalonic AcidemiasMaple Syrup Urine DiseaseCitrullinemia+26 more
West Kazakhstan Medical University 2,250
Testing effectiveness (Phase 2)Looking for participantsNCT06500702
What this trial is testing

Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi 84
Testing effectiveness (Phase 2)Active Not RecruitingNCT03933904
What this trial is testing

Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's Disease, Multicentric
University of Pennsylvania 7
Not applicableEnded earlyNCT04235621
What this trial is testing

Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment-Resistant Minimal Change Disease (TR-MCD), and Diabetic Nephropathy (DN)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseDiabetic Nephropathies
Goldfinch Bio, Inc. 20
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Not applicableUnknownNCT04268485
What this trial is testing

Longitudinal Changes in Serum KL-6 in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Manchester University NHS Foundation Trust 60
Not applicableUnknownNCT05979454
What this trial is testing

Value of KL-6 in Rheumatoid Arthritis-Associated ILD

Who this might be right for
Rheumatoid Arthritis-Associated Interstitial Lung Disease
Assiut University 80
Testing effectiveness (Phase 2)Looking for participantsNCT06983028
What this trial is testing

Atacicept in Multiple Glomerular Diseases

Who this might be right for
pMNIgANNephrotic Syndrome+2 more
Vera Therapeutics, Inc. 200
Not applicableStudy completedNCT03822481
What this trial is testing

Mindful Construal Diaries: Can the MCD Increase Mindfulness and Mindful Eating in Bariatric Surgery Patients

Who this might be right for
Obesity
Birmingham City University 26
Not applicableUnknownNCT01437956
What this trial is testing

KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis

Who this might be right for
Acute Viral Bronchiolitis
University Hospital, Clermont-Ferrand 200
Not applicableStudy completedNCT02270931
What this trial is testing

A Prospective Longitudinal Breast Cancer Study

Who this might be right for
Breast Cancer
Fujirebio Diagnostics, Inc. 130
Load More Results